Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

4.180 +0.040 (+0.97%)
Streaming Delayed Price Updated: 9:44 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Anavex: Alzheimer's To Parkinson's Dementia ↗
Following a huge gain in 2021 (after a big gain in 2020), the shares have given back 27% year-to-date as investors ride out a quiet stretch awaiting trial results. 
Via Talk Markets
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Anavex Life Sciences Corp. (NASDAQ:AVXL) Investor Alert: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 03/21/2022 -- An investigation on behalf of investors in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) was announced over potential breaches of fiduciary duties by... 
Via SBWire
News headline image
Anavex Life Sciences Highlights Biomarker Data From Parkinson's Disease Dementia At International Conference ↗
 
Via Benzinga
News headline image
NASDAQ:AVXL Shareholder Notice: Investigation over Potential Securities Laws Violations by Anavex Life Sciences Corp. ↗
San Diego, CA -- (SBWIRE) -- 02/23/2022 -- Anavex Life Sciences Corp. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Recap: Anavex Life Sciences Q1 Earnings ↗
  Anavex Life Sciences (NASDAQ:AVXL) reported its Q1 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For February 9, 2022 ↗
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. 
Via Benzinga
News headline image
Anavex Life Sciences Says Rett Syndrome Trial Meets Primary & Secondary Goals ↗
Anavex Life Sciences Corp (NASDAQ: AVXL) reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett syndrome. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Los Angeles - (NewMediaWire) - February 04, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life... 
Via NewMediaWire
News headline image
Investigation Notice: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
ANAVEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Anavex Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
23 Stocks Moving in Wednesday's Pre-Market Session ↗
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out: Executives buy more than $600 million of 3... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Rises 50 Points; DLH Holdings Shares Drop ↗
US stocks traded mixed in the afternoon session on Tuesday after recording sharp gains in the previous session. Wall Street closed the volatile January month with steep losses. 
Via Benzinga
News headline image
52 Biggest Movers From Yesterday ↗
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix... 
Via Benzinga
News headline image
Anavex Life Sciences Crashes As Last-Minute Testing Edits Cloud Drug's Impact ↗
Just two weeks ago, Anavex edited the goals of its study in Rett syndrome. 
Via Investor's Business Daily
News headline image
34 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 25.6% to $1.42 during Tuesday's regular session. Trading volume for Windtree Therapeutics's stock is 652.4K... 
Via Benzinga
News headline image
Mid-Day Market Update: Pitney Bowes Drops After Q4 Earnings; Biofrontera Shares Climb ↗
US stocks traded mostly flat on Tuesday after recording sharp gains in the previous session. Wall Street closed the volatile January month with steep losses. 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mostly Lower Following Monday's Rally; UPS Earnings Top Views ↗
US stocks started the first trading day of new month on a cautious note after recording gains on Monday. Wall Street closed the volatile January month with steep losses. 
Via Benzinga
News headline image
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Molecular Partners (NASDAQ:MOLN) shares moved upwards by 11.9% to $31.66 during Friday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
News headline image
Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study ↗
Anavex Life Sciences Corp (NASDAQ: AVXL) announced topline results from its Phase 1 trial of ANAVEX3-71 in development for neurodegenerative diseases, including... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus ↗
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers iSpecimen (NASDAQ:ISPC) shares in... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.